Lidocaine Egis (Lidocaine)

Lidocaine works by blocking voltage‑gated sodium channels on nerve cells. By preventing sodium influx, it stops the generation and propagation of action potentials, which temporarily halts the transmission of pain signals from the treated area to the brain.

The appropriate amount of Lidocaine Egis is determined by the prescribing healthcare professional based on the size of the area to be treated, the patient’s age, and the specific procedure. Patients should follow the exact instructions provided by their clinician and not exceed the recommended application.

Safety data for topical lidocaine in pregnancy and lactation are limited. It should only be used when the potential benefit outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Lidocaine is a widely used amide‑type local anesthetic offering rapid onset and moderate duration of action. Compared with benzocaine, another topical anesthetic, lidocaine generally provides deeper penetration and a longer numbness period, while having a well‑characterised safety profile and lower risk of methemoglobinemia.

Store Lidocaine Egis at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and ensure it is out of reach of children. Do not freeze or expose the product to extreme temperatures.

Lidocaine Egis is applied directly to the skin surface. The clinician cleans the area, spreads a thin layer of the preparation over the target region, and allows it to absorb for the recommended time before proceeding with the procedure. It should not be ingested or injected.

The most serious adverse events include systemic toxicity leading to central nervous system symptoms such as seizures, cardiac arrhythmias or hypotension, and severe allergic reactions like anaphylaxis. These risks are rare but require immediate medical attention if signs such as dizziness, irregular heartbeat, or widespread rash appear.

Individuals with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid using the product. It is also contraindicated in patients with severe heart block, certain cardiac conduction disorders, or those taking medications that may significantly increase lidocaine plasma levels without medical supervision.